TYK2 joined the club of GOF-mutated JAKs causative for patient hematopoietic malignancies only recently: In 2013, the first TYK2 GOF point mutations were found in T-ALL cell lines and characterized to have transforming capacity via STAT1 and a BCL2 family member [53]. This evidence concerns the gene STAT1 and acute lymphoblastic leukemia.